BioAge Labs, Inc. (BIOA)

NMS – Real Time Price. Currency in USD

10.54

-0.13 (-1.22%)

Market open: Aug 12, 2026, 2:08 PM EDT

10.70

+0.03 (0.28%)

Previous after-hours: Aug 11, 2026, 7:43 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-213K

-167K

-162K

-129K

Gross Profit

-167K

-162K

-129K

Operating expenses (excl. COGS)

-102M

-78M

-48M

-40M

Operating Income

-93M

-78M

-48M

-40M

Non-operating income, total

12M

-15M

247K

Pretax income

-81M

-71M

-64M

-40M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-81M

-71M

-64M

-40M

Discontinued operations

Net income

-81M

-71M

-64M

-40M

Dilution adjustment

Preferred dividends

BioAge Labs, Inc. (BIOA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioAge Labs, Inc. (BIOA)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

BioAge Labs, Inc. (BIOA)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

BioAge Labs, Inc. (BIOA)

Income Statement (Annual)

Income Statement (Annual)